Insys To Pay $225M To End DOJ's Opioid Scheme Probe
Insys Therapeutics has agreed to a $225 million global settlement to end criminal and civil investigations by the federal government tied to allegations the pharmaceutical company bribed doctors to prescribe a...To view the full article, register now.
Already a subscriber? Click here to view full article